Maternal circulating angiogenic factors in twin and singleton pregnancies

American Journal of Obstetrics and Gynecology

Volumn 212, Issue 5, 2015, Pages 636.e1-636.e8

  Faupel Badger, Jessica M ^a,b   McElrath, Thomas F ^c   Lauria, Michele ^f   Houghton, Lauren C ^b   Lim, Kee Hak ^e   Parry, Samuel ^g   Cantonwine, David ^c   Lai, Gabriel ^b   Karumanchi, S Ananth ^d   Hoover, Robert N ^b   Troisi, Rebecca ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiogenic balance; endoglin; pregnancy; singletons; soluble fms like tyrosine kinase 1; twins

Indexed keywords

ANGIOGENIC PROTEIN; ENDOGLIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PLACENTA PROTEIN;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; DELIVERY; FEMALE; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLETON PREGNANCY; THIRD TRIMESTER PREGNANCY; TWIN PREGNANCY; ADULT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FIRST TRIMESTER PREGNANCY; SECOND TRIMESTER PREGNANCY;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREGNANCY, TWIN; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84928825150     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.11.035     Document Type: Article

References (33)

1. J.J. Walker Pre-eclampsia Lancet 356 2000 1260 1265
2. B.M. Sibai, J. Hauth, and S. Caritis Hypertensive disorders in twin versus singleton gestations; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units Am J Obstet Gynecol 182 2000 938 942
3. S. Krotz, J. Fajardo, S. Ghandi, A. Patel, and L.G. Keith Hypertensive disease in twin pregnancies: a review Twin Res 5 2002 8 14
4. A. Wang, A.M. Holston, and K.F. Yu Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates J Matern Fetal Neonatal Med 25 2012 1447 1452
5. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
6. R.J. Levine, C. Qian, S.E. Maynard, K.F. Yu, F.H. Epstein, and S.A. Karumanchi Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women Am J Obstet Gynecol 194 2006 1034 1041
7. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
8. J.M. Faupel-Badger, R.N. Fichorova, and E.N. Allred Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation Am J Reprod Immunol 66 2011 488 494
9. S.E. Maynard, and S.A. Karumanchi Angiogenic factors and preeclampsia Semin Nephrol 31 2011 33 46
10. S. Rana, S.A. Karumanchi, and R.J. Levine Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 2007 137 142
11. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
12. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
13. S. Maynard, F.H. Epstein, and S.A. Karumanchi Preeclampsia and angiogenic imbalance Annu Rev Med 59 2008 61 78
14. A.C. Staff, K. Braekke, N.K. Harsem, T. Lyberg, and M.R. Holthe Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia Eur J Obstet Gynecol Reprod Biol 122 2005 33 39
15. R. Thadhani, W.P. Mutter, and M. Wolf First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
16. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
17. S.E. Maynard, S. Venkatesha, R. Thadhani, and S.A. Karumanchi Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia Pediatr Res 57 2005 1 7R
18. N. Ruiz-Sacedon, A. Perales-Puchalt, D. Borras, R. Gomez, and A. Perales Angiogenic growth factors in maternal and fetal serum in concordant and discordant twin pregnancies J Matern Fetal Neonatal Med 27 2014 870 873
19. Y. Bdolah, C. Lam, and A. Rajakumar Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 198 2008 428.e1 428.e6
20. O. Sanchez, E. Llurba, and G. Marsal First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology Hum Reprod 27 2012 358 365
21. T.F. McElrath, K.H. Lim, and E. Pare Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy Am J Obstet Gynecol 207 2012 407.e1 407.e7
22. P.L. Yudkin, M. Aboualfa, J.A. Eyre, C.W. Redman, and A.R. Wilkinson New birthweight and head circumference centiles for gestational ages 24 to 42 weeks Early Hum Dev 15 1987 45 52
23. S.E. Maynard, T.A. Moore Simas, and M.J. Solitro Circulating angiogenic factors in singleton vs multiple-gestation pregnancies Am J Obstet Gynecol 198 2008 200.e1 200.e7
24. E. Bujold, R. Romero, and T. Chaiworapongsa Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin J Matern Fetal Neonatal Med 18 2005 9 16
25. S.R. Murphy, B.B. LaMarca, M. Parrish, K. Cockrell, and J.P. Granger Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha Am J Physiol Regul Integr Comp Physiol 304 2013 R130 R135
26. L. Myatt, R.G. Clifton, and J.M. Roberts Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? BJOG 120 2013 1183 1191
27. O. Nevo, A. Many, and J. Xu Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction J Clin Endocrinol Metab 93 2008 285 292
28. C.E. Powe, R.J. Levine, and S.A. Karumanchi Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease Circulation 123 2011 2856 2869
29. L. Bellamy, J.P. Casas, A.D. Hingorani, and D.J. Williams Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis BMJ 335 2007 974
30. K.M. Aagaard-Tillery, G.J. Stoddard, and C. Holmgren Preeclampsia and subsequent risk of cancer in Utah Am J Obstet Gynecol 195 2006 691 699
31. J.S. Kim, E.J. Kang, and O.H. Woo The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis Acta Oncol 52 2013 1643 1648
32. H.S. Kim, O.H. Woo, and K.H. Park The relationship between twin births and maternal risk of breast cancer: a meta-analysis Breast Cancer Res Treat 131 2012 671 677
33. R. Troisi, K. Braekke, N.K. Harsem, M. Hyer, R.N. Hoover, and A.C. Staff Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies Am J Obstet Gynecol 199 2008 653.e1 653.e10